Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Operating loss
Research and development	$ 9,896	$ 6,216	$ 29,402	$ 16,557
General and administrative	5,556	3,860	16,122	12,359
Gain on sale of Aquinox Canada	0	(7,826)	0	(7,826)
Total operating loss	15,452	2,250	45,524	21,090
Other income (loss), net	6	1	(1)	453
Net loss	$ (15,446)	$ (2,249)	$ (45,525)	$ (20,637)
Net loss per share – basic (in dollars per share)	$ (0.28)	$ (0.04)	$ (0.83)	$ (0.41)
Net loss per share – diluted (in dollars per share)	$ (0.28)	$ (0.04)	$ (0.83)	$ (0.41)
Basic weighted average common shares outstanding (in shares)	55,087,777	54,121,676	55,020,059	50,896,014
Diluted weighted average common shares outstanding (in shares)	55,087,777	54,121,676	55,020,059	50,896,014